STOCK TITAN

[D] Vicarious Surgical Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
D

Vicarious Surgical Inc. (RBOT) filed a Form D reporting a private placement under Rule 506(b)Total Amount Sold of $11,730,000 and Total Remaining $0. The filing notes the total offering amount reflects gross proceeds assuming cash exercise of all warrants issued in the private placement.

The securities include equity, warrants or other rights to acquire securities, and securities to be acquired upon exercise. The Date of First Sale was 2025-10-09. Lake Street Capital Markets, LLC acted as placement agent, receiving a 6.0% cash fee on gross proceeds plus $100,000 expense reimbursement.

The company indicates proceeds are for working capital; while none are specifically set aside for officers or directors, some working capital may indirectly cover executive salaries and director stipends. Industry is listed as Health Care — Biotechnology, and issuer size was marked “Decline to Disclose.”

Vicarious Surgical Inc. (RBOT) ha presentato una Form D riportando un private placement sotto Rule 506(b) con Total Amount Sold of $11,730,000 e Total Remaining $0. La dichiarazione nota che l'importo totale dell'offerta riflette i proventi lordi presumendo l'esercizio in contanti di tutti i warrant emessi nel private placement. Le securities includono equity, warrants or other rights to acquire securities, e securities to be acquired upon exercise. Date of First Sale was 2025-10-09. Lake Street Capital Markets, LLC ha agito come placement agent, ricevendo una 6.0% cash fee sui proventi lordi più $100,000 di rimborso spese. La società indica che i proventi sono destinati al capitale circolante; sebbene non sia specificamente destinato alcun importo per funzionari o amministratori, parte del capitale circolante potrebbe coprire indirettamente stipendi esecutivi e indennità dei direttori. L'industria è indicata come Health Care — Biotechnology, e la dimensione dell'emittente è stata contrassegnata “Decline to Disclose.”
Vicarious Surgical Inc. (RBOT) presentó un Form D reportando una colocación privada bajo Rule 506(b) con un Total Amount Sold of $11,730,000 y Total Remaining $0. El registro señala que el monto total de la oferta refleja ingresos brutos asumiendo el ejercicio en efectivo de todas las warrants emitidos en la colocación privada. Los valores incluyen equity, warrants or other rights to acquire securities, y securities to be acquired upon exercise. Date of First Sale was 2025-10-09. Lake Street Capital Markets, LLC actuó como agente de colocación, recibiendo una 6.0% cash fee sobre los ingresos brutos más un reembolso de gastos de $100,000. La empresa indica que los ingresos son para capital de trabajo; aunque ninguno se aparta específicamente para funcionarios o directores, parte del capital de trabajo podría cubrir indirectamente salarios ejecutivos y estipendios de directores. La industria se enumera como Health Care — Biotechnology, y el tamaño del emisor fue marcado como “Decline to Disclose.”
Vicarious Surgical Inc. (RBOT)는 Rule 506(b)에 따른 비공개 배치를 보고하는 Form D를 제출했으며 Total Amount Sold of $11,730,000Total Remaining $0를 기록했습니다. 제출서는 총 공모 금액이 비공개 배치에서 발행된 모든 워런트의 현금 행사 가정을 전제한 총수입을 반영한다고 명시합니다. 증권은 주식, 주식 취득을 위한 권리인 워런트 또는 기타 권리, 그리고 행사 시 매입할 보안을 포함합니다. First Sale Date는 2025-10-09입니다. Lake Street Capital Markets, LLC가 배치 대리인으로 활동했으며 매출 gross 수익의 6.0%의 현금 수수료와 $100,000의 비용 상환을 받았습니다. 회사에 따르면 수익은 운전자본으로 사용되며, 임원이나 이사에게 특별히 배정된 금액은 없지만 일부 운전자본은 간접적으로 임원 급여 및 이사 수당을 충당할 수 있습니다. 업종은 Health Care — Biotechnology로 기재되어 있으며, 발행자 규모는 “Decline to Disclose.”
Vicarious Surgical Inc. (RBOT) a déposé un Form D signalant un placement privé sous la Rule 506(b) avec un Total Amount Sold of $11,730,000 et Total Remaining $0. Le dépôt indique que le montant total de l'offre reflète des produits bruts en supposant l'exercice en espèces de tous les warrants émis dans le placement privé. Les titres comprennent des actions, des warrants ou d'autres droits d'acquérir des titres, et des titres à acquérir lors de l'exercice. Date of First Sale was 2025-10-09. Lake Street Capital Markets, LLC a agi en tant qu'agent de placement, recevant une commission en espèces de 6,0% sur les produits bruts plus un remboursement des dépenses de $100,000. La société indique que les produits servent de fonds de roulement; bien qu'aucun montant ne soit spécifiquement mis de côté pour les dirigeants ou administrateurs, une partie du fonds de roulement pourrait indirectement couvrir les salaires des cadres et les indemnités des administrateurs. L'industrie est indiquée comme Health Care — Biotechnology, et la taille de l'émetteur a été marquée « Decline to Disclose ».
Vicarious Surgical Inc. (RBOT) hat ein Form D eingereicht und eine Privatplatzierung unter Rule 506(b) gemeldet mit Total Amount Sold of $11,730,000 und Total Remaining $0. Das Filing vermerkt, dass der Gesamtangebot Betrag die Bruttoerlöse unter der Annahme des Cash Exercise aller in der Privatplatzierung ausgegebenen Warrants widerspiegelt. Die Wertpapiere umfassen Eigenkapital, Warrants oder andere Rechte zum Erwerb von Wertpapieren, und Wertpapiere, die bei Ausübung erworben werden sollen. Das Date of First Sale was 2025-10-09. Lake Street Capital Markets, LLC fungierte als Platzierungsmittler und erhielt eine 6,0%-Cash-Fees auf Bruttoerlöse zuzüglich $100,000 Kostenerstattung. Das Unternehmen gibt an, die Erlöse seien für Working Capital bestimmt; während kein Betrag ausdrücklich für Angestellte oder Direktoren vorgesehen ist, könnte etwas Working Capital indirekt Gehälter der Führungskräfte und Vorstandsaufwendungen decken. Die Branche ist als Health Care — Biotechnology angegeben, und die Emittenten-Größe wurde als „Decline to Disclose“ markiert.
قدمت شركة Vicarious Surgical Inc. (RBOT) نموذج D للإبلاغ عن وضع خاص بموجب Rule 506(b) مع Total Amount Sold of $11,730,000 و Total Remaining $0. تشير التسجيل إلى أن إجمالي مبلغ العرض يعكس العوائد الإجمالية بافتراض ممارسة نقدية لكل الضمانات المصدرة في الوضع الخاص. تشمل الأوراق المالية حقوق الملكية، الضمانات أو حقوق أخرى لاكتساب الأوراق المالية، و الأوراق المالية التي ستتم شراؤها عند التمرين. Date of First Sale was 2025-10-09. عملت Lake Street Capital Markets, LLC كوكيل وضع، وحصلت على عمولة نقدية قدرها 6.0% من العوائد الإجمالية بالإضافة إلى تعويض عن المصاريف قدره $100,000. تشير الشركة إلى أن العوائد مخصصة لرأس المال العامل؛ بينما لا يوجد تخصيص محدد للمسؤولين أو directors، قد يغطي جزء من رأس المال العامل رواتب التنفيذيين وتكاليف أعضاء مجلس الإدارة بشكل غير مباشر. Industry مدرجة ك Health Care — Biotechnology، وحجم المُصدر مُحدد بأنه “Decline to Disclose.”
Vicarious Surgical Inc. (RBOT) 提交了 Form D,报告在 Rule 506(b) 下进行私募配售,Total Amount Sold of $11,730,000Total Remaining $0。该备案指出,若现金行使本次私募配售中发行的所有认股权证则募集总额为毛收益。证券包括 股权认股权证或其他取得证券的权利,以及 行使时应获得的证券Date of First Sale was 2025-10-09。Lake Street Capital Markets, LLC 担任配售代理,获得毛收益的 6.0% 现金费用及 $100,000 的费用报销。公司表示募集资金用于运营资金;虽然没有专门为高管或董事设定特定用途,但部分运营资金可能间接覆盖执行薪资和董事津贴。行业被列为 Health Care — Biotechnology,发行人规模被标注为“Decline to Disclose”。
Positive
  • None.
Negative
  • None.
Vicarious Surgical Inc. (RBOT) ha presentato una Form D riportando un private placement sotto Rule 506(b) con Total Amount Sold of $11,730,000 e Total Remaining $0. La dichiarazione nota che l'importo totale dell'offerta riflette i proventi lordi presumendo l'esercizio in contanti di tutti i warrant emessi nel private placement. Le securities includono equity, warrants or other rights to acquire securities, e securities to be acquired upon exercise. Date of First Sale was 2025-10-09. Lake Street Capital Markets, LLC ha agito come placement agent, ricevendo una 6.0% cash fee sui proventi lordi più $100,000 di rimborso spese. La società indica che i proventi sono destinati al capitale circolante; sebbene non sia specificamente destinato alcun importo per funzionari o amministratori, parte del capitale circolante potrebbe coprire indirettamente stipendi esecutivi e indennità dei direttori. L'industria è indicata come Health Care — Biotechnology, e la dimensione dell'emittente è stata contrassegnata “Decline to Disclose.”
Vicarious Surgical Inc. (RBOT) presentó un Form D reportando una colocación privada bajo Rule 506(b) con un Total Amount Sold of $11,730,000 y Total Remaining $0. El registro señala que el monto total de la oferta refleja ingresos brutos asumiendo el ejercicio en efectivo de todas las warrants emitidos en la colocación privada. Los valores incluyen equity, warrants or other rights to acquire securities, y securities to be acquired upon exercise. Date of First Sale was 2025-10-09. Lake Street Capital Markets, LLC actuó como agente de colocación, recibiendo una 6.0% cash fee sobre los ingresos brutos más un reembolso de gastos de $100,000. La empresa indica que los ingresos son para capital de trabajo; aunque ninguno se aparta específicamente para funcionarios o directores, parte del capital de trabajo podría cubrir indirectamente salarios ejecutivos y estipendios de directores. La industria se enumera como Health Care — Biotechnology, y el tamaño del emisor fue marcado como “Decline to Disclose.”
Vicarious Surgical Inc. (RBOT)는 Rule 506(b)에 따른 비공개 배치를 보고하는 Form D를 제출했으며 Total Amount Sold of $11,730,000Total Remaining $0를 기록했습니다. 제출서는 총 공모 금액이 비공개 배치에서 발행된 모든 워런트의 현금 행사 가정을 전제한 총수입을 반영한다고 명시합니다. 증권은 주식, 주식 취득을 위한 권리인 워런트 또는 기타 권리, 그리고 행사 시 매입할 보안을 포함합니다. First Sale Date는 2025-10-09입니다. Lake Street Capital Markets, LLC가 배치 대리인으로 활동했으며 매출 gross 수익의 6.0%의 현금 수수료와 $100,000의 비용 상환을 받았습니다. 회사에 따르면 수익은 운전자본으로 사용되며, 임원이나 이사에게 특별히 배정된 금액은 없지만 일부 운전자본은 간접적으로 임원 급여 및 이사 수당을 충당할 수 있습니다. 업종은 Health Care — Biotechnology로 기재되어 있으며, 발행자 규모는 “Decline to Disclose.”
Vicarious Surgical Inc. (RBOT) a déposé un Form D signalant un placement privé sous la Rule 506(b) avec un Total Amount Sold of $11,730,000 et Total Remaining $0. Le dépôt indique que le montant total de l'offre reflète des produits bruts en supposant l'exercice en espèces de tous les warrants émis dans le placement privé. Les titres comprennent des actions, des warrants ou d'autres droits d'acquérir des titres, et des titres à acquérir lors de l'exercice. Date of First Sale was 2025-10-09. Lake Street Capital Markets, LLC a agi en tant qu'agent de placement, recevant une commission en espèces de 6,0% sur les produits bruts plus un remboursement des dépenses de $100,000. La société indique que les produits servent de fonds de roulement; bien qu'aucun montant ne soit spécifiquement mis de côté pour les dirigeants ou administrateurs, une partie du fonds de roulement pourrait indirectement couvrir les salaires des cadres et les indemnités des administrateurs. L'industrie est indiquée comme Health Care — Biotechnology, et la taille de l'émetteur a été marquée « Decline to Disclose ».
Vicarious Surgical Inc. (RBOT) hat ein Form D eingereicht und eine Privatplatzierung unter Rule 506(b) gemeldet mit Total Amount Sold of $11,730,000 und Total Remaining $0. Das Filing vermerkt, dass der Gesamtangebot Betrag die Bruttoerlöse unter der Annahme des Cash Exercise aller in der Privatplatzierung ausgegebenen Warrants widerspiegelt. Die Wertpapiere umfassen Eigenkapital, Warrants oder andere Rechte zum Erwerb von Wertpapieren, und Wertpapiere, die bei Ausübung erworben werden sollen. Das Date of First Sale was 2025-10-09. Lake Street Capital Markets, LLC fungierte als Platzierungsmittler und erhielt eine 6,0%-Cash-Fees auf Bruttoerlöse zuzüglich $100,000 Kostenerstattung. Das Unternehmen gibt an, die Erlöse seien für Working Capital bestimmt; während kein Betrag ausdrücklich für Angestellte oder Direktoren vorgesehen ist, könnte etwas Working Capital indirekt Gehälter der Führungskräfte und Vorstandsaufwendungen decken. Die Branche ist als Health Care — Biotechnology angegeben, und die Emittenten-Größe wurde als „Decline to Disclose“ markiert.

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM D

Notice of Exempt Offering of Securities

OMB APPROVAL
OMB Number: 3235-0076
Estimated average burden
hours per response: 4.00

1. Issuer's Identity

CIK (Filer ID Number) Previous Names
None
Entity Type
0001812173
D8 Holdings Corp.
X Corporation
Limited Partnership
Limited Liability Company
General Partnership
Business Trust
Other (Specify)

Name of Issuer
Vicarious Surgical Inc.
Jurisdiction of Incorporation/Organization
DELAWARE
Year of Incorporation/Organization
X Over Five Years Ago
Within Last Five Years (Specify Year)
Yet to Be Formed

2. Principal Place of Business and Contact Information

Name of Issuer
Vicarious Surgical Inc.
Street Address 1 Street Address 2
78 FOURTH AVENUE
City State/Province/Country ZIP/PostalCode Phone Number of Issuer
WALTHAM MASSACHUSETTS 02451 (617) 868-1700

3. Related Persons

Last Name First Name Middle Name
From Stephen
Street Address 1 Street Address 2
78 Fourth Avenue
City State/Province/Country ZIP/PostalCode
Waltham MASSACHUSETTS 02451
Relationship: X Executive Officer X Director Promoter

Clarification of Response (if Necessary):

Chief Executive Officer
Last Name First Name Middle Name
Sachs Adam
Street Address 1 Street Address 2
78 Fourth Avenue
City State/Province/Country ZIP/PostalCode
Waltham MASSACHUSETTS 02451
Relationship: X Executive Officer X Director Promoter

Clarification of Response (if Necessary):

President
Last Name First Name Middle Name
Romano Sarah
Street Address 1 Street Address 2
78 Fourth Avenue
City State/Province/Country ZIP/PostalCode
Waltham MASSACHUSETTS 02451
Relationship: X Executive Officer Director Promoter

Clarification of Response (if Necessary):

Chief Financial Officer
Last Name First Name Middle Name
Khalifa Sammy
Street Address 1 Street Address 2
78 Fourth Avenue
City State/Province/Country ZIP/PostalCode
Waltham MASSACHUSETTS 02451
Relationship: X Executive Officer X Director Promoter

Clarification of Response (if Necessary):

Chief Technology Officer
Last Name First Name Middle Name
Carr-Brendel Victoria
Street Address 1 Street Address 2
78 Fourth Avenue
City State/Province/Country ZIP/PostalCode
Waltham MASSACHUSETTS 02451
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Clark Randy
Street Address 1 Street Address 2
78 Fourth Avenue
City State/Province/Country ZIP/PostalCode
Waltham MASSACHUSETTS 02451
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Ho David
Street Address 1 Street Address 2
78 Fourth Avenue
City State/Province/Country ZIP/PostalCode
Waltham MASSACHUSETTS 02451
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Huss Beverly
Street Address 1 Street Address 2
78 Fourth Avenue
City State/Province/Country ZIP/PostalCode
Waltham MASSACHUSETTS 02451
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Ahmad Fuad
Street Address 1 Street Address 2
78 Fourth Avenue
City State/Province/Country ZIP/PostalCode
Waltham MASSACHUSETTS 02451
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Doherty Joseph
Street Address 1 Street Address 2
78 Fourth Avenue
City State/Province/Country ZIP/PostalCode
Waltham MASSACHUSETTS 02451
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


4. Industry Group

Agriculture
Banking & Financial Services
Commercial Banking
Insurance
Investing
Investment Banking
Pooled Investment Fund
Is the issuer registered as
an investment company under
the Investment Company
Act of 1940?
Yes No
Other Banking & Financial Services
Business Services
Energy
Coal Mining
Electric Utilities
Energy Conservation
Environmental Services
Oil & Gas
Other Energy
Health Care
Biotechnology
Health Insurance
Hospitals & Physicians
Pharmaceuticals
X Other Health Care
Manufacturing
Real Estate
Commercial
Construction
REITS & Finance
Residential
Other Real Estate
Retailing
Restaurants
Technology
Computers
Telecommunications
Other Technology
Travel
Airlines & Airports
Lodging & Conventions
Tourism & Travel Services
Other Travel
Other

5. Issuer Size

Revenue Range OR Aggregate Net Asset Value Range
No Revenues No Aggregate Net Asset Value
$1 - $1,000,000 $1 - $5,000,000
$1,000,001 - $5,000,000 $5,000,001 - $25,000,000
$5,000,001 - $25,000,000 $25,000,001 - $50,000,000
$25,000,001 - $100,000,000 $50,000,001 - $100,000,000
Over $100,000,000 Over $100,000,000
X Decline to Disclose Decline to Disclose
Not Applicable Not Applicable

6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)

Rule 504(b)(1) (not (i), (ii) or (iii))
Rule 504 (b)(1)(i)
Rule 504 (b)(1)(ii)
Rule 504 (b)(1)(iii)
X Rule 506(b)
Rule 506(c)
Securities Act Section 4(a)(5)
Investment Company Act Section 3(c)
Section 3(c)(1) Section 3(c)(9)
Section 3(c)(2) Section 3(c)(10)
Section 3(c)(3) Section 3(c)(11)
Section 3(c)(4) Section 3(c)(12)
Section 3(c)(5) Section 3(c)(13)
Section 3(c)(6) Section 3(c)(14)
Section 3(c)(7)

7. Type of Filing

X New Notice Date of First Sale 2025-10-09 First Sale Yet to Occur
Amendment

8. Duration of Offering

Does the Issuer intend this offering to last more than one year?
Yes X No

9. Type(s) of Securities Offered (select all that apply)

X Equity Pooled Investment Fund Interests
Debt Tenant-in-Common Securities
X Option, Warrant or Other Right to Acquire Another Security Mineral Property Securities
X Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security Other (describe)

10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
Yes X No

Clarification of Response (if Necessary):

11. Minimum Investment

Minimum investment accepted from any outside investor $0 USD

12. Sales Compensation

Recipient
Recipient CRD Number None
Lake Street Capital Markets, LLC 000164447
(Associated) Broker or Dealer X None
(Associated) Broker or Dealer CRD Number X None
None None
Street Address 1 Street Address 2
121 South 8th Street Suite 1000
City State/Province/Country ZIP/Postal Code
Minneapolis MINNESOTA 55402
State(s) of Solicitation (select all that apply)
Check "All States" or check individual States
All States
Foreign/non-US
NEW YORK

13. Offering and Sales Amounts

Total Offering Amount $11,730,000 USD
or Indefinite
Total Amount Sold $11,730,000 USD
Total Remaining to be Sold $0 USD
or Indefinite

Clarification of Response (if Necessary):

The total offering amount reflects the total gross proceeds to be received assuming cash exercise of all warrants issued in the private placement.

14. Investors

Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, and enter the number of such non-accredited investors who already have invested in the offering.
Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering:
1

15. Sales Commissions & Finder's Fees Expenses

Provide separately the amounts of sales commissions and finders fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.

Sales Commissions $351,897 USD
Estimate
Finders' Fees $0 USD
Estimate

Clarification of Response (if Necessary):

The placement agent received a cash placement fee equal to 6.0% of the gross proceeds received from the sale of the securities sold in the registered direct offering and the concurrent private placement, plus expense reimbursement of $100,000.

16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.

$0 USD
Estimate

Clarification of Response (if Necessary):

While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to executive officers and to paying director stipends.

Signature and Submission

Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.

Terms of Submission

In submitting this notice, each issuer named above is:
  • Notifying the SEC and/or each State in which this notice is filed of the offering of securities described and undertaking to furnish them, upon written request, in the accordance with applicable law, the information furnished to offerees.*
  • Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator or other legally designated officer of the State in which the issuer maintains its principal place of business and any State in which this notice is filed, as its agents for service of process, and agreeing that these persons may accept service on its behalf, of any notice, process or pleading, and further agreeing that such service may be made by registered or certified mail, in any Federal or state action, administrative proceeding, or arbitration brought against the issuer in any place subject to the jurisdiction of the United States, if the action, proceeding or arbitration (a) arises out of any activity in connection with the offering of securities that is the subject of this notice, and (b) is founded, directly or indirectly, upon the provisions of: (i) the Securities Act of 1933, the Securities Exchange Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, or the Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii) the laws of the State in which the issuer maintains its principal place of business or any State in which this notice is filed.
  • Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Rule 504 or Rule 506 for one of the reasons stated in Rule 504(b)(3) or Rule 506(d).

Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.

For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.

Issuer Signature Name of Signer Title Date
Vicarious Surgical Inc. /s/ Stephen From Stephen From Chief Executive Officer 2025-10-15

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

* This undertaking does not affect any limits Section 102(a) of the National Securities Markets Improvement Act of 1996 ("NSMIA") [Pub. L. No. 104-290, 110 Stat. 3416 (Oct. 11, 1996)] imposes on the ability of States to require information. As a result, if the securities that are the subject of this Form D are "covered securities" for purposes of NSMIA, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot routinely require offering materials under this undertaking or otherwise and can require offering materials only to the extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.


Vicarious Surgical Inc

NYSE:RBOT

RBOT Rankings

RBOT Latest News

RBOT Latest SEC Filings

RBOT Stock Data

39.81M
4.76M
22.63%
33.75%
2.19%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
WALTHAM